Discovery and characterization of novel indole and 7-azaindole derivatives as inhibitors of β-amyloid-42 aggregation for the treatment of Alzheimer's disease

Bioorg Med Chem Lett. 2017 Mar 15;27(6):1405-1411. doi: 10.1016/j.bmcl.2017.02.001. Epub 2017 Feb 4.

Abstract

The aggregation of amyloid-β peptides into cytotoxic oligomeric and fibrillary aggregates is believed to be one of the major pathological events in Alzheimer disease. Here we report the design and synthesis of a novel series of indole and 7-azaindole derivatives containing, nitrile, piperidine and N-methyl-piperidine substituents at the 3-position to prevent the pathological self-assembly of amyloid-β. We have further demonstrated that substitution of the azaindole and indole derivatives at the 3 positions is required to obtain compounds with improved physicochemical properties to allow brain penetration.

Keywords: Alzheimer’s disease; Azaindole derivatives; Aβ aggregation; Indole derivatives; Inhibitors; Structure-activity relationship.

MeSH terms

  • Alzheimer Disease / prevention & control*
  • Amyloid beta-Peptides / antagonists & inhibitors*
  • Animals
  • Brain / drug effects
  • Drug Discovery*
  • Humans
  • Indoles / pharmacology*
  • Liver / drug effects
  • Male
  • Mice
  • Peptide Fragments / antagonists & inhibitors*

Substances

  • 7-azaindole dimer
  • Amyloid beta-Peptides
  • Indoles
  • Peptide Fragments
  • amyloid beta-protein (1-42)